5-hydroxytryptophan production strain as well as construction method and application thereof

Through gene editing technology, E. coli strain was transformed and the efficient 5-hydroxytryptophan production strain E. coli HTP20 was constructed, which solved the problem of high cost of existing production methods and achieved efficient and efficient without the need for addition of precursors and antibiotics. 5-hydroxytryptophan production has enhanced the prospects of industrial application.

CN118979005AActive Publication Date: 2024-11-19TIANJIN UNIV OF SCI & TECH +1

Patent Information

Application Number
CN202411471828.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-22
Publication Date
2024-11-19
Estimated Expiration
2044-10-22

AI Technical Summary

Technical Problem

The existing 5-hydroxytryptophan production methods are costly, and the direct microbial fermentation method has not been fully developed and utilized, making it difficult to replace the traditional production methods.

Method used

Through gene editing technology, E.coli HTP11 was modified, genes of E.coli subtilis and Corynebacterium glutamate were introduced, the coenzyme supply system and plasmid system were optimized, specific genes were knocked out, and efflux proteins were overexpressed, and efficient 5-hydroxytryptophan production strain E. coli HTP20.

Benefits of technology

It realizes efficient production of 5-hydroxytryptophan without the need for addition of precursors and antibiotics, reducing production costs, increasing yield and industrial application prospects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118979005A_ABST
    Figure CN118979005A_ABST
Patent Text Reader

Abstract

The invention provides a 5-hydroxytryptophan production strain and a construction method and application thereof, the genetic background of the strain is clear, a purFbsubK316Q mutant gene derived from bacillus subtilis is heterologously introduced on the basis of the 5-hydroxytryptophan production strain E.coli HTP11, the transcriptional level of guaB, guaA, gmk and ndk genes of the strain E.coli HTP11 is up-regulated, a gapX gene derived from corynebacterium glutamicum is heterologously introduced, and the mutant gene is a mutant gene derived from bacillus subtilis. According to the 5-hydroxytryptophan gene disclosed by the invention, aromatic amino acid internal transporter serB, tnaB and aroP genes are deleted, the transcriptional level of an intimal efflux transporter yhjV gene is up-regulated, and a pTm-serB plasmid is electrically transferred, so that a direct precursor 5-hydroxytryptophan of 5-hydroxytryptophan can be stably provided, and the 5-hydroxytryptophan gene has efficient 5-hydroxytryptophan output capability.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of compound biotechnology production, and in particular to a 5-hydroxytryptophan-producing strain, its construction method, and its application. Background Technology

[0002] 5-Hydroxytryptophan (5-HTP), chemically known as 5-hydroxy-3-indolyl-α-aminopropionic acid, is a precursor in the biosynthesis of the neurotransmitter serotonin. It can effectively treat various diseases, such as depression, fibromyalgia, obesity, insomnia, and chronic headaches. In recent years, with the exploration of the functions of 5-HTP, it has become one of the most commercially valuable minor amino acids.

[0003] my country is a major producer of 5-HTP, and natural product synthesis remains the primary method for its production. This method utilizes seeds from Ghanaian plants as raw materials, undergoing a series of complex processes to ultimately obtain pure 5-HTP. While this yields high-purity 5-HTP products, the raw material costs are high, and plant extraction carries significant environmental burdens. Enzymatic catalysis, on the other hand, requires the addition of the precursor tryptophan, and the enzyme catalysis process necessitates the participation of coenzymes, resulting in higher costs.

[0004] At present, direct microbial fermentation has become the preferred alternative to current production methods due to its advantages such as low cost, simple process, and ease of industrialization, and it awaits further development and utilization. Summary of the Invention

[0005] The technical problem to be solved by the present invention is to provide a 5-hydroxytryptophan-producing strain.

[0006] Another technical problem to be solved by the present invention is to provide a method for constructing the above-mentioned 5-hydroxytryptophan-producing strain.

[0007] Another technical problem to be solved by the present invention is to provide the application of the above-mentioned 5-hydroxytryptophan producing strain.

[0008] To solve the above-mentioned technical problems, the technical solution of the present invention is as follows: A 5-hydroxytryptophan-producing strain, which is a strain E. coli HTP20 It is an artificially modified Escherichia coli with a specific genotype ( E.coli W3110 ): In strain E.coli HTP11 Heterologous introduction of Bacillus subtilis-derived genes into the genome purF bsu K316Q The mutated gene upregulated the strain E.coli HTP11 of guaB , guaA , gmk , ndkAt the transcriptional level, heterologous introduction of *Corynebacterium glutamicum*-derived genes... gapX The gene lacks an aromatic amino acid transporter. serB , tnaB , aroP Genes upregulated endometrial efflux transport proteins yhjV The gene was transcribed at the transcriptional level and electrotransfused into the pTm-serB plasmid.

[0009] Preferably, the above-mentioned 5-hydroxytryptophan-producing strain, the starting strain E. coli HTP11 The strain in patent publication number CN115948311A E.coli HTP11 .

[0010] Preferably, the above-mentioned 5-hydroxytryptophan-producing strain will produce Bacillus subtilis spores. purF bsu K316Q The mutant gene was integrated into the genome and its expression was enhanced using the TRC promoter; *Corynebacterium glutamicum*-derived... gapX Genes are integrated into the genome and their expression is enhanced using the trc promoter; guaB , guaA , yhjV Genes are overexpressed onto the genome and their expression is enhanced using the TRC promoter; gmk , ndk Genes were overexpressed onto the genome and their expression was enhanced using the lac promoter; genes on the strain genome were knocked out. serB , tnaB , aroP Gene.

[0011] Preferably, the above-mentioned 5-hydroxytryptophan-producing strain, purF bsu K316Q The mutant gene underwent a site-directed mutation, where the base at position 946 was changed from A to C, resulting in the amino acid residue at position 316 being changed from lysine (K) to glutamine (Q).

[0012] Preferably, in the above-mentioned 5-hydroxytryptophan-producing strain, the nucleotide sequence of the lac promoter is shown in SEQ ID NO.1, and the nucleotide sequence of the trc promoter is shown in SEQ ID NO.2. purF bsu K316Q The nucleotide sequence of the mutant gene is shown in SEQ ID NO.3 of the sequence listing. gapX The nucleotide sequence of the gene is shown in SEQ ID NO.4 of the sequence listing. guaB The nucleotide sequence of the gene is shown in SEQ ID NO.5 of the sequence listing. guaAThe nucleotide sequence of the gene is shown in SEQ ID NO.6 of the sequence listing. gmk The nucleotide sequence of the gene is shown in SEQ ID NO.7 of the sequence listing. ndk The nucleotide sequence of the gene is shown in SEQ ID NO.8 of the sequence listing. yhjV The nucleotide sequence of the gene is shown in SEQ ID NO.9 of the sequence listing. serB The nucleotide sequence of the gene is shown in SEQ ID NO.10 of the sequence listing. tnaB The nucleotide sequence of the gene is shown in SEQ ID NO.11 of the sequence listing. aroP The nucleotide sequence of the gene is shown in SEQ ID NO.12, and the nucleotide sequence of the pTm-serB plasmid is shown in SEQ ID NO.13.

[0013] The above-mentioned method for constructing 5-hydroxytryptophan-producing strains, with E.coli HTP11 As the starting strain (chassis strain), gene editing was performed using metabolic engineering techniques, with the following specific steps: (1) An enzyme encoding Bacillus subtilis-derived amide phosphoribosyltransferase is integrated into the genome. purF bsu K316Q The mutated gene was then started using the trc promoter. (2) E. coli-derived genes were integrated into the genome. guaB , guaA Genes, and start them using the trc promoter; (3) E. coli-derived genes were integrated into the genome. gmk , ndk Genes, and are promoted using the lac promoter; (4) It integrates into the genome a gene encoding glyceraldehyde-3-phosphate dehydrogenase derived from Corynebacterium glutamicum. gapX Genes, and start them using the trc promoter; (5) The gene encoding phosphoserine phosphatase was knocked out in the genome. serB Gene; (6) The genome encoding the tryptophan internal transporter was knocked out. tnaB, aroP Gene; (7) The genome integrates proteins encoding efflux proteins. yhjV Gene; (8) Electroporate the pTm-serB plasmid into the strain modified in step (7).

[0014] Application of the above-mentioned 5-hydroxytryptophan-producing strains in the fermentation production of 5-hydroxytryptophan.

[0015] Preferably, the above-mentioned 5-hydroxytryptophan-producing strain is used to produce 5-hydroxytryptophan in a fermenter, specifically through the following method: (1) Slant culture: The 5-hydroxytryptophan producing strain was inoculated on slant medium as the first generation slant culture and cultured at 36-37℃ for 12-14h; the colonies of the first generation slant culture were inoculated on a new slant medium as the second generation slant culture and cultured at 36-37℃ for 10-12h. (2) Seed culture: The bacterial growth from the second-generation slant was washed with sterile water and transferred to the seed culture medium. The culture temperature was 34-36℃. The pH of the seed culture was maintained at 7.0±0.2 and the dissolved oxygen value was 40-50% by automatically adding ammonia solution controlled by a bioreactor. The OD of the seed culture was... 600nm Once the temperature reaches 15-20, proceed to the next stage of fermentation. (3) Fermentation culture: The inoculum amount is 20%, the culture temperature is 34-36℃, and the pH of the seed culture is maintained at 6.2-7.2 and the dissolved oxygen value is 30%-50% by automatically adding ammonia solution through the bioreactor.

[0016] Preferably, in the application of the above-mentioned 5-hydroxytryptophan producing strain, the slant culture medium used in step (1) is the general LB solid culture medium.

[0017] Preferably, in the application of the above-mentioned 5-hydroxytryptophan-producing strain, the seed culture medium used in step (2) is: glucose 20-40 g / L, yeast extract powder 4-6 g / L, ammonium sulfate 2-5 g / L, potassium dihydrogen phosphate 1-3 g / L, anhydrous magnesium sulfate 0.5-2 g / L, ferrous sulfate heptahydrate 20-40 mg / L, manganese sulfate monohydrate 10-20 mg / L, V H 0.1-0.5 mg / L, V B1 0.5-1 mg / L, the remainder is water.

[0018] Preferably, in the application of the above-mentioned 5-hydroxytryptophan-producing strain, the fermentation medium used in step (3) is: glucose 20-40 g / L, yeast extract powder 3-6 g / L, peptone 2-5 g / L, ammonium sulfate 4-8 g / L, potassium dihydrogen phosphate 3-6 g / L, anhydrous magnesium sulfate 2-4 g / L, ferrous sulfate heptahydrate 40-60 mg / L, manganese sulfate monohydrate 20-40 mg / L, V H 0.1-0.5 mg / L, V B1 0.5-1 mg / L, the remainder being water.

[0019] All of the above-mentioned culture media can be prepared using standard methods.

[0020] Beneficial effects: The above-mentioned 5-hydroxytryptophan-producing strains have a clear genetic background and are among the 5-hydroxytryptophan-producing strains. E.coli HTP11 Based on this, it can stably provide 5-hydroxytryptophan, the direct precursor of 5-hydroxytryptophan, and in E.coli HTP11 In the tryptophan hydroxylation module, the coenzyme supply system was optimized, including the supply of synthetic raw materials and reducing power, and the stability of the plasmid system was optimized, resulting in a highly efficient 5-hydroxytryptophan export capability. Specifically: First, in 5-hydroxytryptophan-producing bacteria E.coli HTP11 Based on this, the supply system of coenzyme tetrahydropterin was optimized, which increased the carbon flux of the GTP synthesis pathway, the raw material for tetrahydropterin synthesis, made the tryptophan hydroxylase coenzyme expression system more efficient, and enhanced the reducing power supply of the tetrahydropterin cycling pathway. Next, the tryptophan supply system and plasmid system of the engineered bacteria were coupled and optimized. By coupling the tryptophan supply system and plasmid system, the supply of the precursor tryptophan and the stability of hydroxylated tryptophan in the strain were improved, specifically through genome knockout in the strain. serB Genes cause a serine deficiency, and serine is a precursor to tryptophan synthesis. serB Gene addition is performed on the plasmid, i.e. serB The gene acts as an antibiotic-free selection tag, and the high copy number of the plasmid enhances the carbon flux of the serine synthesis pathway, ensuring a sufficient supply of serine, the precursor of the tryptophan synthesis pathway. During fermentation, due to the selection pressure of the antibiotic-free selection tag, there is no need to add antibiotics to ensure the stability of plasmid replication. Finally, the export system of 5-hydroxytryptophan was modified. By knocking out aromatic amino acid transport proteins and overexpressing efflux proteins, 5-hydroxytryptophan could be rapidly exported to the extracellular space, improving the ability of engineered bacteria to transport 5-hydroxytryptophan to the extracellular space. The resulting 5-hydroxytryptophan engineered strain used glucose as a carbon source, and the fermentation process did not require the addition of 5-hydroxytryptophan precursors or antibiotics, showing good prospects for industrial application. Attached Figure Description

[0021] Figure 1 This is the spectrum of plasmid pTm-serB.

[0022] Figure 2 5-Hydroxytryptophan-producing strain E. coli HTP20 Fermentation process curve. Detailed Implementation

[0023] To enable those skilled in the art to better understand the technical solution of the present invention, the technical solution of the present invention will be further described in detail below with reference to specific embodiments.

[0024] Unless otherwise specified, the percentage sign "%" used in the examples refers to the mass percentage. The percentage of a solution refers to the number of grams of solute contained in 100 mL. The percentage between liquids refers to the volume ratio of the solution at 25°C.

[0025] The corresponding promoters and genes in the examples are shown in the sequence listing. The primers used in the construction of the strains involved are shown in Table 1.

[0026] Table 1 Primers used in strain construction Primer Sequence number Sequence ycdN-US SEQ ID NO.14 GATTTTGACGCCACCAACACC ycdN-UA SEQ ID NO.15 GTTATCCGCTCACAATTCCACACATTATACGAGCCGGATGATTAATTGTCAACCAATCCACATCACACAATCCATC ycdN-DS SEQ ID NO.16 CTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCCTGAGTAGGACAAATGAAGGGATTTTTGGCTATCAGG ycdN-DA SEQ ID NO.17 CATATCGTATTCGCCAGGCTG purF-3 SEQ ID NO.18 GTGTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGACCATGCTTGCTGAAATCAAAGGCTT purF1-1C-A SEQ ID NO.19 GCCTGTTGCCTCTGCATAGCCGATCGCCGCTGAAATACTGGAAACCGG purF1-2C-S SEQ ID NO.20 CGGCTATGCAGAGGCAACAGGCATTCCGTATGAGCTTGGCTTAATCCAAAACCGTTATGTTGG purF1-3-A SEQ ID NO.21 GTGTCCAAGTGTCAATGCCG purF1-3-S SEQ ID NO.22 CGGCATTGACACTTGGACACAT purF-4 SEQ ID NO.23 GATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTCGTTTTATTTGTTATTTGGTTAATACTGCTTCTTTTACGTGAGG pGRB-ycdN-s SEQ ID NO.24 AGTCCTAGGTATAATACTAGTCATTACTGCGTGAAGGCGCGGTTTTAGAGCTAGAA pGRB-ycdN-a SEQ ID NO.25 TTCTAGCTCTAAAACCGCGCCTTCACGCAGTAATGACTAGTATTATACCTAGGACT yjiT-US SEQ ID NO.26 AATAGTTGTTGCCGCCTGAGT yjiT-UA SEQ ID NO.27 TGTGTGAAATTGTTATCCGCTCAATTCCACACATTATACGAGCCGGATGATTAATTGTCAAAAAACAGGCAGCAAAGTCCC yjiT-DS SEQ ID NO.28 AAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCCTGAGTAGGACAAATAAGCACTACCTGTGAAGGGATGT yjiT-DA SEQ ID NO.29 CAGGGCTTCCACAGTCACAAT guaA-trc-s SEQ ID NO.30 TCCGGCTCGTATAATGTGTGGAATTGTGAGCGGATAACAATTTCACAGGAAACAGACCATGACGGAAAACATTCATAAG guaA-trc-a SEQ ID NO.31 CACCGACAAACAACAGATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTCGTTTTATTTGTCATTCCCACTCAATGGTA pGRB-yjiT-s SEQ ID NO.32 AGTCCTAGGTATACTAGTAGGGATTATGAACGGCAATGGTTTTAGAGCTAGAA pGRB-yjiT-a SEQ ID NO.33 TTCTAGCTCTAAAACCATTGCCGTTCATAATCCCTACTAGTATTATACCTAGGACT yjiP-US SEQ ID NO.34 GCCATACCGCCAGCAAGAT yjiP-UA SEQ ID NO.35 AATTGTTATCCGCTCACAATTCCACACATTATACGAGCCGGATGATTAATTGTCAAGCAGATATTCCCCTTTCCACC yjiP-DS SEQ ID NO.36 AAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCCTGAGTAGGACAAATGACGGATGACAAACGCAAAGC yjiP-DA SEQ ID NO.37 AAAGGCGGATTTTTACTGTGGA guaB-trc-s SEQ ID NO.38 TCCGGCTCGTATAATGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGACCATGCTACGTATCGCTAAAGAAG guaB-trc-a SEQ ID NO.39 CACCGACAAACAACAGATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTCGTTTTATTTGTCAGGAGCCCAGACGGTAG pGRB-yjiP-s SEQ ID NO.40 AGTCCTAGGTATAATACTAGTCTTTGTCGATGAAAAATTGCGTTTTAGAGCTAGAA pGRB-yjiP-a SEQ ID NO.41 TTCTAGCTCTAAAACGCAATTTTTCATCGACAAAGACTAGTATTATACCTAGGACT ylbE-US SEQ ID NO.42 ACCCAACCTTACGCAACCAG ylbE-UA SEQ ID NO.43 AATTGTTATCCGCTCACAATTCCACACATTATACGAGCCGGATGATTAATTGTCAATTGTTCGATAACCGCAGCAT ylbE-DS SEQ ID NO.44 AAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCCTGAGTAGGACAAATCGCTGGCGTGCTTTGAA ylbE-DA SEQ ID NO.45 GGCGTAACTCAGCAGGCAG gmk-lac-s SEQ ID NO.46 TTCCGGCTCGTATGTTGTGTGGAATTGTGAGCGGATAACTCACACAGGAAACAGACCATGGCTCAAGGCACGCTTTAT gmk-lac-a SEQ ID NO.47 TTATCCGCTCACAATTCCACACATTATACGAGCCGGATGATTAATTGTCAAAGTCATAGTAATCCAGCAACTCTTGTG pGRB-ylbE-s SEQ ID NO.48 AGTCCTAGGTATAATACTAGTACACTGGCTGGATGTGCAACGTTTTAGAGCTAGAA pGRB-ylbE-a SEQ ID NO.49 TTCTAGCTCTAAAACGTTGCACATCCAGCCAGTGTACTAGTATTATACCTAGGACT ΔserB-US SEQ ID NO.50 ATGCCTAACATTACCTGGTGCGA ΔserB-UA SEQ ID NO.51 GTGAAATTGTTATCCGCTCACAATTCCACACATTATACGAGCCGGATGATTAATTGTCAACCCGGCGTGCGCAGGTGCGGG ΔserB-DS SEQ ID NO.52 AAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCCTGAGTAGGACAAATGCGATTGCCTCCGGCGGCT ΔserB-DA SEQ ID NO.53 TTACTTCTGATTCAGGCTGCCTGA ndk-lac-s SEQ ID NO.54 TTCCGGCTCGTATGTTGTGTGGAATTGTGAGCGGATAACTCACACAGGAAACAGACCATGGCTATTGAACGTACT ndk-lac-a SEQ ID NO.55 TGTGCCCGCGCACCCGTTAACAAATAAAACGAAAGGCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTG pGRB-serB-s SEQ ID NO.56 AGTCCTAGGTATAATACTAGTGTAACCGAACGGGCGATGCGGTTTTAGAGCTAGAA pGRB-serB-a SEQ ID NO.57 TTCTAGCTCTAAAACCGCATCGCCCGTTCGGTTACACTAGTATTATACCTAGGACT ΔtnaB-US SEQ ID NO.58 CTGCTGCGTTTAACCATTCC ΔtnaB-UA SEQ ID NO.59 TGTGTGAAATTGTTATCCGCTCACAATTCCACACATTATACGAGCCGGATGATTAATTGTCAACCGGCAAGATCAACAGGTAAA ΔtnaB-DS SEQ ID NO.60 ACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCCTGAGTAGGACAAATAGACCGTTTCTTCGCCATTTAA ΔtnaB-DA SEQ ID NO.61 AATCAGTGGCACTTTGGCATG gapX-trc-s SEQ ID NO.62 TCCGGCTCGTATAATGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGACCATGACGCACAACCACAAGGACT gapX-trc-a SEQ ID NO.63 CGACAAACAACAGATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTCGTTTTATTTGCTATAGTACGGCTGGCTGCCT pGRB-tnaB-s SEQ ID NO.64 AGTCCTAGGTATAATACTAGTCGACGCCACCAGCTCCACTGGTTTTAGAGCTAGAA pGRB-tnaB-a SEQ ID NO.65 TTCTAGCTCTAAAACCAGTGGAGCTGGTGGCGTCGACTAGTATTATACCTAGGACT ΔaroP-US SEQ ID NO.66 CAGCACGGCGAGCAGCTAAAGCGC ΔaroP-UA SEQ ID NO.67 GTGAAATTGTTATCCGCTCACAATTCCACACATTATACGAGCCGGATGATTAATTGTCAAGGCGGCAGAAACCCAGGTGGGG ΔaroP-DS SEQ ID NO.68 AAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCCTGAGTAGGACAAATCTGTCGATAAACGTGGTGT ΔaroP-DA SEQ ID NO.69 CTGTTTAAAGAGAAAACCGCCAAAG yhjV-trc-s SEQ ID NO.70 TCCGGCTCGTATAATGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGACCATGCAGCACAACACACTATCGA yhjV-trc-a SEQ ID NO.71 ACCGACAAACAACAGATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTCGTTTTATTTGTTACTCAATCAGCTTCAACAG pGRB-aroP-s SEQ ID NO.72 AGTCCTAGGTATACTAGTCGTTAGCAACCTGTGGGATCGTTTTAGAGCTAGAA pGRB-aroP-a SEQ ID NO.73 TTCTAGCTCTAAAACGATCCCACAGGTTGCTAACGACTAGTATTATACCTAGGACT TM2-S SEQ ID NO.74 ACAGCAAATGGGTCGCGGATCCATGAAACTGGAAGATGTACCGTGG TM2-A SEQ ID NO.75 GTGCTCGAGTGCGGCCGCATTATGTATCTTTCAAAATTTCGATACTCTG TM2-line-S SEQ ID NO.76 CAGAGTATCGAAATTTTGAAAGATACATAATGCGGCCGCACTCGAGCAC TM2-line-A SEQ ID NO.77 CCACGGTACATCTTCCAGTTTCATGGATCCGCGACCCATTTGCTGT serB-line-S SEQ ID NO.78 TGAAATTGTTATCCGCTCACAATTCCACAACATACGAGCCGGAAGCATAAAGTGTAAACGGGATCTCGACGCTCTCC serB-line-A SEQ ID NO.79 TCTCAGGCAGCCTGAATCAGAAGTAAGCGCAACGCCAATTAATGTAAGT serB-S SEQ ID NO.80 ACTTACATTAATTGCGTTGCGCTTACTTCTGATTCAGGCTGCCTGAGA serB-A SEQ ID NO.81 TCGTATGTTGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGCTATGCCTAACATTACCTGGTGCGA The gene editing methods used in the gene manipulations in this embodiment are referenced in the literature (Li Y, Lin Z, Huang C, et al. Metabolic engineering of Escherichia coli using CRISPR-Cas9 meditated genomeediting. Metabolic Engineering, 2015, 31: 13-21.). Unless otherwise specified, all technical terms used in this invention are explained in this article. In this invention, "knockout" refers to the inactivation of the target gene, and "introduction" refers to the insertion of a foreign gene into the engineered bacterial genome after linking it with a promoter and terminator.

[0027] Example 1 This embodiment aims to illustrate the strain. E. coli HTP20 The specific construction steps are detailed below. In particular, if there are similar gene manipulation methods in the examples, only one instance will be provided and annotated, without further elaboration.

[0028] ①In ycdN Pseudogene sites are controlled using the TRC promoter. purF bsu fbr Gene overexpression: by E.coliW3110Using the genome as a template, upstream and downstream homologous arms were obtained by amplification with ycdN-US / ycdN-UA and ycdN-DS / ycdN-DA, respectively. Then, mutant nucleotide sequences were designed onto purF1-1C-A, purF1-2C-S, purF1-3-A, and purF1-3-S, with homologous sequences between purF1-1C-A / purF1-2C-S and purF1-3-A / purF1-3-S. Using the Bacillus subtilis genome as a template, PCR amplification was performed using primers purF-3 / purF1-1C-A, purF1-2C-S / purF1-3-A, and purF1-3-S / purF-4 to obtain fragments 1, 2, and 3, respectively. Then, using fragments 1, 2, and 3 as templates, overlap PCR was performed using primers purF-3 / purF-4 to obtain the target fragment P. trc - purF bsu fbr Using upstream and downstream homologous arms and the target gene fragment as templates, and with ycdN-US and ycdN-DA as primers, overlapping fragments were amplified by overlapping PCR to obtain overlapping fragments; using pGRB-ycdN-s and pGRB-ycdN-a as primers, gRNA fragments were annealed to obtain gRNA fragments, which were then ligated to the pGRB vector to obtain pGRB-ycdN; preparation E.coli HTP11 Electroporation was performed on competent cells. The target fragment and pGRB-ycdN were co-electroporated into competent cells, and positive transformants were screened to obtain the bacterial strain. E.coli HTP13 .

[0029] ②In yjiT Pseudogene sites are controlled using the TRC promoter. guaA Gene overexpression: by E.coliW3110 Using the genome as a template, upstream and downstream homologous arms and the target gene fragment were amplified by PCR using yjiT-US / yjiT-UA, yjiT-DS / yjiT-DA, and guaA-trc-s / guaA-trc-a, respectively. Then, using the upstream and downstream homologous arms and the target gene fragment as templates, overlapping fragments were amplified by overlapping PCR using yjiT-US and yjiT-DA primers. Annealing was performed using pGRB-yjiT-s and pGRB-yjiT-a primers to obtain the gRNA fragment, which was then ligated into the pGRB vector to obtain pGRB-yjiT. Preparation... E. coli HTP13 Electroporation was performed on competent cells. The target fragment and pGRB-yjiT were co-electroporated into competent cells, and positive transformants were selected to obtain the bacterial strain. E. coli HTP14 .

[0030] ③ In yjiPPseudogene sites are controlled using the TRC promoter. guaB Gene expression: It uses the same operational method as in ②, the difference being that the primers used are yjiP-US / yjiP-UA, yjiP-DS / yjiP-DA, guaB-trc-s / guaB-trc-a, pGRB-yjiP-s, and pGRB-yjiP-a. The competent cells are... E. coli HTP14 Obtain strain E.coli HTP15 .

[0031] ④ In ylbe Pseudogene loci are controlled by the lac promoter. gmk Gene expression: It uses the same operational method as in ②, the difference being that the primers used are ylbE-US / ylbE-UA, ylbE-DS / ylbE-DA, gmk-lac-s / gmk-lac-a, pGRB-ylbE-s, and pGRB-ylbE-a. The competent cells are... E. coli HTP15 Obtain strain E. coli HTP16 .

[0032] ⑤ In serB Gene loci are controlled using the lac promoter. ndk Gene expression: It employs the same operational method as in ②, the difference being that the primers used are ΔserB-US / ΔserB-UA, ΔserB-DS / ΔserB-DA, ndk-lac-s / ndk-lac-a, pGRB-serB-s, and pGRB-serB-a. The competent cells are... E. coli HTP16 Obtain strain E.coli HTP17 .

[0033] ⑥ In tnaB Gene loci are controlled using TRC promoters. gapX Gene expression: It uses the same operational method as in ②, the difference being that the primers used are ΔtnaB-US / ΔtnaB-UA, ΔtnaB-DS / ΔtnaB-DA, gapX-trc-s / gapX-trc-a, pGRB-tnaB-s, and pGRB-tnaB-a. The competent cells are... E. coli HTP17 Obtain strain E.coli HTP18 .

[0034] ⑦ In aroP Gene loci are controlled using TRC promoters. yhjV Gene expression: It uses the same operational method as in ②, the difference being that the primers used are ΔaroP-US / ΔaroP-UA, ΔaroP-DS / ΔaroP-DA, yhjV-trc-s / yhjV-trc-a, pGRB-aroP-s, and pGRB-aroP-a. The competent cells are... E. coli HTP18 Obtain strain E.coli HTP19 .

[0035] ⑧Preparation E. coli HTP19 Electroporation of competent cells: After electroporating the plasmid pTm-serB into competent cells, positive transformants were selected to obtain... E.coli HTP20 .

[0036] Example 2 This embodiment aims to illustrate the construction method of plasmid pTm-serB in Example 1. The pTm-serB plasmid map can be found in [link to example]. Figure 1 For details regarding the genes and promoters involved, please refer to CN115948311A. The specific steps are as follows: ⑨ Using the artificially synthesized gene TM2 as a template and TM2-S and TM2-A as primers, the TM2 fragment with homologous regions to the pet-28a linear vector was amplified. Using the pet-28a empty plasmid (purchased from EasyShare Biotechnology (Tianjin) Co., Ltd.) as a template and TM2-line-S and TM2-line-A as primers, the pet-28a linear vector with homologous regions to the TM2 fragment was amplified. The TM2 gene fragment and the linear vector were ligated with recombinase to obtain a plasmid carrying the TM2 gene.

[0037] ⑩ has the same operation method as ⑨, except that the primers used are serB-S / serB-A and serB-line-S / serB-line-A, and the plasmid template used is the plasmid constructed in step ⑨.

[0038] The linearization vector and gene fragment ligation method can use any recombinase. In this embodiment, the ClonExpress® rapid cloning technology from Nanjing Novizan Biotechnology Co., Ltd. was used to construct the overexpression plasmid. The final nucleotide sequence of the plasmid pTm-serB is shown in SEQ ID NO.13 of the sequence listing.

[0039] Example 3 Using the strain described in Example 1 E.coli HTP20 The specific steps for producing 5-hydroxytryptophan by fermentation in a 5L mechanically stirred fermenter are as follows: (1) Slant culture: The 5-hydroxytryptophan producing strain was inoculated on slant medium as the first generation slant culture and cultured at 36-37℃ for 12h; the slant medium was the general LB solid medium; the colonies of the first generation slant culture were inoculated on a new slant medium as the second generation slant culture and cultured at 36-37℃ for 10h. (2) Seed culture: The bacterial growth from the second-generation slant was washed with sterile water and transferred to the seed culture medium. The culture temperature was 36℃. A 25% ammonia solution was automatically added via a 5L bioreactor to maintain the pH of the seed culture at 7.0±0.2 and the dissolved oxygen value at 40-50%. The OD of the seed culture was... 600nm Once the concentration reaches 20, the next fermentation stage begins. The seed culture medium used is: glucose 30 g / L, yeast extract 4 g / L, ammonium sulfate 2 g / L, potassium dihydrogen phosphate 3 g / L, anhydrous magnesium sulfate 1 g / L, ferrous sulfate heptahydrate 20 mg / L, manganese sulfate monohydrate 10 mg / L, and vitamin C. H 0.5 mg / L, V B1 0.5 mg / L, the remainder being water; (3) Fermentation culture: The inoculum size was 20%, and the culture temperature was 36℃. A 25% ammonia solution was automatically added via a bioreactor to maintain the pH of the seed culture at 7.0±0.2 and the dissolved oxygen value at 30%-50%. The fermentation medium used was: glucose 20g / L, yeast extract 4g / L, peptone 2g / L, ammonium sulfate 4g / L, potassium dihydrogen phosphate 3g / L, anhydrous magnesium sulfate 2g / L, ferrous sulfate heptahydrate 60 mg / L, manganese sulfate monohydrate 30 mg / L, V H 0.5 mg / L, V B1 1 mg / L, the remainder being water; after the glucose in the culture medium is consumed, add 80% (m / v) glucose solution to maintain the glucose concentration in the fermentation medium at 0.1-1 g / L; the fermentation cycle is 32 h.

[0040] like Figure 2 As shown, after 32 hours of fermentation in a 5 L fermenter, the yield of 5-hydroxytryptophan reached 16.8 g / L. This invention discloses a method for constructing and applying engineered bacteria to increase 5-hydroxytryptophan yield. The engineered bacteria constructed using this method... E. coli HTP20 It is a production strain that synthesizes 5-hydroxytryptophan de novo from glucose, without the need to add precursor 5-hydroxytryptophan or antibiotics, which has significant technical advantages.

[0041] The above description is only a preferred embodiment of the present invention. It should be noted that for those skilled in the art, several improvements and modifications can be made without departing from the principle of the present invention. Improvements and modifications such as strain modification based on the method of the present invention or based on the method are all considered to be within the scope of protection of the present invention.

Claims

1. A 5-hydroxytryptophan producing strain, Features: In strain E.coli HTP11 Subtilis subtilis spore-derived genes F bsu K316Q Mutated gene, upregulated strain E.coli HTP11 of guaB , guA , gmk , ndk The transcription level of the gene was increased by heterologous introduction of the gapX Gene, missing serB Gene, tnaB Gene, aroP Gene, up-regulated inner membrane efflux transporter Yj Y The transcription level of the gene was measured and electroporated into the pTm-serB plasmid.

2. The 5-hydroxytryptophan producing strain according to claim 1, Features: Subtilis subtilis spores F bsu K316Q The mutant gene was integrated into the genome and the expression was enhanced by using the trc promoter; gapX The gene is integrated into the genome and the expression is enhanced by using the trc promoter; guaB Gene, guA Gene, Yj Y Genes are overexpressed on the genome and the expression is enhanced by using the trc promoter; gmk Gene, ndk Genes are overexpressed on the genome and the expression is enhanced using the lac promoter; Knockout strain genome serB Gene, tnaB Gene, aroP Gene.

3. The 5-hydroxytryptophan producing strain according to claim 2, Features: The nucleotide sequence of the lac promoter is shown in the sequence listing SEQ ID NO.1, the nucleotide sequence of the trc promoter is shown in the sequence listing SEQ ID NO.2, F bsu K316Q The nucleotide sequence of the mutant gene is shown in the sequence table SEQ ID NO.

3. gapX The nucleotide sequence of the gene is shown in the sequence table SEQ ID NO.

4. guaB The nucleotide sequence of the gene is shown in the sequence table SEQ ID NO.

5. guA The nucleotide sequence of the gene is shown in the sequence table SEQ ID NO.

6. gmk The nucleotide sequence of the gene is shown in the sequence table SEQ ID NO.

7. ndk The nucleotide sequence of the gene is shown in the sequence table SEQ ID NO.

8. Yj Y The nucleotide sequence of the gene is shown in the sequence table SEQ ID NO.9, serB The nucleotide sequence of the gene is shown in the sequence table SEQ ID NO.

10. tnaB The nucleotide sequence of the gene is shown in the sequence table SEQ ID NO.

11. aroP The nucleotide sequence of the gene is shown in the sequence listing SEQ ID NO.12, and the nucleotide sequence of the pTm-serB plasmid is shown in the sequence listing SEQ ID NO.

13.

4. A method for constructing a 5-hydroxytryptophan producing strain according to any one of claims 1 to 3, Features: by E. coli HTP11 As a starting strain, the specific steps are as follows: (1) The genome is integrated with a gene encoding a gene derived from Bacillus subtilis F bsu K316Q The mutant gene was driven by the trc promoter; (2) The E. coli-derived guaB Gene, guA gene, and driven by the trc promoter; (3) The E. coli-derived gmk Gene, ndk gene, and driven by the lac promoter; (4) A gene encoding 3-phosphoglyceraldehyde dehydrogenase from Corynebacterium glutamicum was integrated into the genome. gapX gene, and driven by the trc promoter; (5) The gene encoding phosphoserine phosphatase was knocked out in the genome serB Gene; (6) The gene encoding the tryptophan transporter was knocked out in the genome tnaB Gene 、aroP Gene; (7) The gene encoding the efflux protein is integrated into the genome Yj Y Gene; (8) Electroporate the pTm-serB plasmid into the transformed strain in step (7).

5. Use of the 5-hydroxytryptophan producing strain according to any one of claims 1 to 3 in the fermentation production of 5-hydroxytryptophan.

6. The use according to claim 5, Features: The method for producing 5-hydroxytryptophan by fermentation in a fermenter is as follows: (1) Slant culture: Take the 5-hydroxytryptophan producing strain and inoculate it on the slant medium as the first generation slant culture, and culture it at 36-37℃ for 12-14h; take the colony of the first generation slant culture and inoculate it on a new slant medium as the second generation slant culture, and culture it at 36-37℃ for 10-12h; (2) Seed culture: Wash the second-generation slant with sterile water and transfer it to the seed culture medium. The culture temperature is 34-36°C. The bioreactor is controlled to automatically add ammonia solution to maintain the pH of the seed solution at 7.0±0.2, the dissolved oxygen value at 40-50%, and the OD of the seed solution at 1. 600nm When the temperature reaches 15-20, the next step of fermentation culture is carried out; (3) Fermentation culture: The inoculation amount is 20%, the culture temperature is 34-36°C, and the bioreactor is controlled to automatically add ammonia solution to maintain the seed liquid pH at 6.2-7.2 and the dissolved oxygen value at 30%-50%.

7. The use according to claim 6, Features: The slant culture medium used in step (1) is a universal LB solid culture medium.

8. The use according to claim 6, Features: The seed culture medium used in step (2) is: 20-40 g / L glucose, 4-6 g / L yeast extract powder, 2-5 g / L ammonium sulfate, 1-3 g / L potassium dihydrogen phosphate, 0.5-2 g / L anhydrous magnesium sulfate, 20-40 mg / L ferrous sulfate heptahydrate, 10-20 mg / L manganese sulfate monohydrate, V H 0.1-0.5 mg / L, V B1 0.5-1 mg / L, the rest is water.

9. The use according to claim 6, Features: The fermentation medium used in step (3) is: 20-40 g / L glucose, 3-6 g / L yeast extract powder, 2-5 g / L peptone, 4-8 g / L ammonium sulfate, 3-6 g / L potassium dihydrogen phosphate, 2-4 g / L anhydrous magnesium sulfate, 40-60 mg / L ferrous sulfate heptahydrate, 20-40 mg / L manganese sulfate monohydrate, V H 0.1-0.5 mg / L, V B1 0.5-1 mg / L, the rest is water.

Citation Information

Patent Citations

  • Gene element combination, recombinant plasmid combination, genetic engineering strain and method for high yield of N-acetyl serotonin

    CN113528557A

  • Genetically engineered bacterium for producing 5-hydroxytryptophan, and construction method and application of genetically engineered bacterium

    CN113549588A

  • Genetically engineered bacterium for producing 5-hydroxytryptophan as well as construction method and application of genetically engineered bacterium

    CN115948311A

  • L-isoleucine production strain as well as construction method and application thereof

    CN117925666A

  • Genetically engineered bacterium for producing L-tryptophan as well as construction method and application of genetically engineered bacterium

    CN118086167A

Cited By

  • L-tryptophan production strain as well as construction method and application thereof

    CN119709578A

  • Production method of pentahydroxy tryptophan

    CN121575058A